Global Cancer Research Institute (GCRI), Inc.

Gilroy, California 95020

0 studies enrolling now · 3 studies all time

What they study most

Adenocarcinoma, Carcinoma, Carcinoma, Large Cell, Colorectal Cancer Metastatic, Follicular Lymphoma, Lung Neoplasm, Non-Small Cell Lung Cancer, Squamous Cell Carcinoma

Studies at this site

• Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer — APPROVED_FOR_MARKETING
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed
• Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly — Completed